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Ab-PET Perioperative MI Perioperative UA Late events
AD (n = 26) 2 8 3
FD In ~ 31) 1 0 4
Normal (n = 20) 2 1 0
Among 26 pts with RD (19 of whom were on anti-anginal therapy at the
time of surgery), only 10 (38%) had perioperative events. The extent of is-
chemia in pts with RD having events (9 ± 7 segments) exceeded that in pts
with RD not having events (6 ± 4 segments, p = NS). In pts with RD, 7/10
pts with events had extensive ischemia (>5 segments), compared with 9/16
without events (p = NS).
Conclusion. Absence of RD by PET confers a low probability of events (es-
pecially UA), comparable to conventional imaging. FD by PET are not associ-
ated with events. However, RD at PET has a low specificity for peri-operative
events (irrespective of extent of RDI; avoidance of events in the absence of
myocardial revascularization may be attributable to medical and anesthetic
measures.
surement of the extent of ischemia, and is highly specific for the diagnosis
of coronary disease.
We investigated the benefit of more accurate identification of ischemia
and a lower frequency of false positives by using PET for risk stratification
in 77 pts (68 ± 9 y, 52 males) undergoing VS (including 39 aortic operations
- 51 %) without recent myocardial revascularization. One or more clinical
risk factors (age> 70, diabetes, angina, prior infarction or heart failure) were
present in 63 pts; 32 had >2 factors. PET followed infusion of 60 mCi of Rb-
82 at rest and after dipyridamole-handgrip stress. Using a quantitative color
scale in a 24 segment model of the left ventricle, scans were reported as nor-
mal, fixed defects only (FD) or reversible (deterioration> 15% with stress)
defects (RD). Events included infarction (MI) and unstable angina (UA), peri-
operatively and at late follow-up (17 ± 6 months) in 74 pts.
Fourteen pts (18%) suffered peri-operative events (5 MI, 9 UA, no cardiac
deaths) giving PET-RD a sensitivity of 71 %. Of 63 pts without events, RD
was present in 16 (p = 0.003) giving a specificity of 66%. Seven pts suffered
late events;
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for a double blind 18-month multi-centre trial comparing picotamide (300
mg t.i.d.), an antiplatelet drug which inhibits thromboxane A2 (TxA2) syn-
thase and antagonizes TxA2 receptor, and placebo. In the study population
as a whole, 151 events (13.1 %) occurred on placebo and 122 (10.6%) on
picotamide, with a relative risk reduction of 19%, (p = 0.056, Logrank test,
intention to treat analysis). The effect of picotamide was assessed in the
A.D.E.P subgroup of diabetic patients, in order to test if the drug was still
effective in patients at higher risk of cardiovascular complications. Diabetic
patients were 438 (230 on picotamide and 208 on placebo). Most of them
were male (80%), with a mean age of 64 years (min 40, max 75). Six per cent
were insulin-dependent. The main risk factors (smoking, hypertension, pre-
vious vascular surgery, anklelarm pressure ratio, WBC count and fibrinogen I
were similarly distributed in the two groups.
Diabetic POAD patients on placebo suffered from a total of 33 cardiovas-
cular events (12 major and 21 minor) (15.9%), whereas those on picotamide
suffered from a total of 20 events (6 major and 14 minor) (8. 7%) (relative re-
duction of risk: 45.2%, p = 0.022 at Logrank test, intention to treat analysis).
Both major and minor events occurred more frequently in the placebo than
in the picotamide group. The overall incidence of major events was 5.8% on
placebo and 2.6% on picotamide (relative risk reduction of 59.8%). Death
occurred in 6 patients on placebo (2.9%) and in 3 on picotamide (1.3%1.
Non fatal major events (stroke, myocardial infarction and amputation) were
6 on placebo and 3 on picotamide. Minor events were 10.1 % on placebo
and 6.1 % on picotamide (relative risk reduction of 39.8%). Adverse reaction,
mainly gastrointestinal, occurred in 16% of patients, regardless of the treat-
ment.
In conclusion, this analysis indicates that Picotamide significantly reduces
cardiovascular events in diabetic POAD patients, suggesting its potential use
in patients at high risk of atherosclerotic progression.
A temporal relation has been established between cocaine ingestion and
acute myocardial infarction. Based on in vitro data, an increase in platelet
aggregation has been hypothesized as a factor contributing to ischemic
events following cocaine abuse. To determine whether cocaine administra-
tion increases platelet aggregation in vivo, 12 healthy volunteers were stud-
ied twice, each subject receiving cocaine (2 mglkg intranasally) or placebo
in a double-blind, randomized, crossover fashion. Aggregation was tested at
baseline and 40, 80 and 120 minutes following administration of the study
drug, using a turbidimetric method. Aggregation was induced using arachi-
donic acid (AA, 625 /lM), epinephrine (5, 10 and 25 /lM), and ADP (1, 2, 4
and 10 /lM). Data are expressed as difference in aggregation (%) [cocaine -
placebo]:
Agonist (/lM) Baseline 40 min 80 min 120 min
ADP 1 o± 1 o± 1 -2 ± 1 -2± 2
2 1 ± 3 o± 2 -4± 2 -5± 3
4 6±5 -2 ± 5 -6± 6 -10± 8
10 4±3 -1± 3 -1± 3 -8± 3
Epinephrine 5 2±9 O± 9 -4± 6 -11 ± 7
10 -6 ± 7 -6± 4 -5± 4 -11 ± 7
25 3±6 -3 ± 4 -5± 6 -13± 6
AA 625 11 ±8 3 ± 12 -3± 11 -2± 14
Data are presented as mean ± SEM. By doubly repeated ANOVA, there
was a decrease in aggregation after cocaine no matter which of these 3
agonists were used (p < 0.05).
Conclusions: These data do not support an increase in platelet aggrega-
tion as a primary cause of myocardial infarction following low dose cocaine
administration. It is unlikely that low dose cocaine causes a direct thrombo-
genic effect. No conclusion can be reached for high dose cocaine.
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Asymptomatic CAD has been shown to be associated with a high risk of pe-
rioperative cardiac events in patients (pts) undergoing surgery for peripheral
vascular disease (PVD). Dipyridamole thallium (SPECT) scintigraphy (DTS)
is considered the most useful screening test for stratification of these pts.
Comparative prospective evaluation of various noninvasive tests for detec-
tion of latent CAD in PVD pts is lacking. In this study, 100 consecutive pa-
tients referred for PVD surgery were evaluated by DTS, low work load ex-
ercise treadmill test (En) and ambulatory ECG monitoring (AEM). Pts with
abnormal findings on any of the three noninvasive tests were evaluated with
coronary angiography (angio) for further stratification. Fifty-five pts had re-
versible perfusion defects on DTS. Of the 55 + pts with DTS, 49 had data
on AEM with 39% having evidence of ambulatory ischemia; 48 of the 55 pts
performed Enwith ischemia induced in 13%. Olthe 41 pts with normal DTS
findings, 12 (29%) had ischemia during En (n = 6) or AEM (n = 61; 64% of
these pts had multi-vessel CAD by angio. Statistical modeling and analysis
of important clinical variables, AEM ischemia, and angio findings were com-
pared with DTS for predicting CAD. These analyses revealed that family hx of
CAD, chest pain, smoking, age ~ 65 years, and ischemia on AEM were highly
predictive of CAD with a positive predictive value of 89% and a specificity of
92%. These findings suggest that a careful evaluation of clinical parameters
and AEM results can provide reliable and clinically meaningful data predictive
of significant CAD in pts referred for PVD surgery.
Conclusion: Our data have demonstrated that the findings on DTS are not
always reliable and its routine use might not be warranted in preoperative
evaluation of patients with asymptomatic CAD referred for peripheral vascu-
lar surgery.
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Introduction: Immediately after arising in the morning there is an increase
in the incidence of acute myocardial infarction, stroke and sudden death.
Upon assumption of the upright posture platelet aggregation, as measured
by conventional techniques using platelet rich plasma, occurs more readily
in response to standard aggregating agents. Whether platelet aggregability
in the physiological milieu of whole blood also increases and whether this in-
crease in platelet aggregability is also accompanied by activation-dependent
